Simultaneous COVID-19, Influenza Vaccines Comparable with Sequential Immunization
Drug Topics
JANUARY 7, 2025
Researchers compared simultaneous and sequential administration of the mRNA COVID-19 and inactivated influenza vaccines.
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Drug Topics
JANUARY 7, 2025
Researchers compared simultaneous and sequential administration of the mRNA COVID-19 and inactivated influenza vaccines.
Drug Topics
JULY 31, 2024
Catch up on important immunization news from the month of July.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
SEPTEMBER 2, 2024
Catch up on important immunization news from the month of August.
Drug Topics
DECEMBER 7, 2022
The shingles vaccine appears to confer long-term immunity, according to research.
Drug Topics
JANUARY 3, 2025
Researchers explored ideas of simplifying the vaccination process to yield higher rates of adult immunization, similar to that of the COVID-19 pandemic.
Drug Topics
MARCH 26, 2024
Posters presented at the APhA 2024 Annual Meeting and Exposition discussed pharmacist barriers in pediatric immunizations, a novel meningococcal vaccine, and the need for inpatient reviews of vaccination history.
STAT
FEBRUARY 28, 2024
has unveiled an advertising campaign aimed at boosting vaccination rates in children, which have steadily fallen over the past decade and took an even greater dip during the height of the Covid-19 pandemic. LONDON — Facing a growing outbreak of measles, the U.K. Read the rest…
Drug Topics
MARCH 27, 2024
mRNA-1283 generated a stronger immune response against both the Omicron BA.4/BA.5 5 and the original virus strains of SARS-CoV-2 compared with Spikevax, Moderna’s licensed COVID-19 vaccine.
Drug Topics
DECEMBER 24, 2023
Vaccine approvals included two immunizations for RSV and a new pentavalent meningococcal shot.
Pharmacy Times
AUGUST 23, 2022
Francesca Ceddia, MD, senior vice president of respiratory vaccines at Moderna, said the company is in early stages of development for a combined mRNA vaccine for influenza, COVID-19, and RSV.
Pharmacy Times
AUGUST 2, 2023
A panel of experts review the criteria used to select a specific high-dose flu vaccine formulation for immunization.
STAT
JUNE 10, 2024
Moderna announced Monday that, in a Phase 3 clinical trial, its combination Covid-19 and influenza vaccine generated stronger immune responses in older adults than individual vaccines that target those viruses. Continue to STAT+ to read the full story…
Drug Topics
SEPTEMBER 25, 2024
Catch up on important immunization news from the month of September.
Drug Topics
OCTOBER 31, 2023
The combination vaccine produced robust immune responses from vaccine candidates in a phase 1/2 clinical trial.
Drug Topics
JANUARY 17, 2023
The updates include new recommendations for COVID-19 and pneumococcal vaccines.
Drug Topics
APRIL 24, 2024
In response to historically low flu vaccine coverage rates, Kristen Thorson, PharmD, urges pharmacists to think back to their pandemic immunization efforts and “know the power of their recommendation,” to boost public protection from influenza.
Pharmacy Times
DECEMBER 13, 2023
Fractional COVID-19 dosing resulted in fewer adverse effects and costs while producing similar immune responses compared to a full dose vaccine.
Drug Topics
OCTOBER 21, 2024
Researchers explored the overall efficacy of various pediatric vaccines and their effects on antibiotic use, while also addressing vaccine hesitancy among parents.
Drug Topics
AUGUST 30, 2022
This National Immunization Awareness Month, prepare your pharmacy to offer important vaccines.
Pharmacy Times
SEPTEMBER 25, 2023
For community pharmacists, cooler temperatures, school buses on the roads and Friday night football are not just signs of a changing season – they are indicators that patients will soon be seeking vaccinations for the 2023-2024 respiratory illness season.
Drug Topics
MAY 21, 2024
Research presented at DDW 2024 found there was no significant association between immune response and hepatitis B vaccine types in patients with Hepatitis C.
Pharmacy Times
AUGUST 15, 2024
RSV and influenza vaccines demonstrated hemagglutination inhibition titers that were noninferior to those with sequential administration.
Pharmacy Times
DECEMBER 27, 2024
Individuals who refused a pneumococcal vaccine were associated with low collective responsibility and confidence in vaccine efficacy and safety.
Drug Topics
OCTOBER 7, 2023
During a podcast hosted by Permanente Medicine, Sandra Fryhofer, MD, chair-elect of the Board of Trustees for the American Medical Association and a liaison to the CDC’s Advisory Committee on Immunization Practices, discussed the importance of vaccines for the fall and winter seasons.
European Pharmaceutical Review
JUNE 13, 2023
If approved, VLA1553 could become the first licensed chikungunya vaccine” A single vaccination of VLA1553 has been shown to produce neutralising antibody levels, thought to protect against chikungunya disease in 99 percent of Phase III trial participants. What did the chikungunya vaccine study results show?
Pharmacy Times
NOVEMBER 14, 2022
Despite evidence of a higher risk of myocarditis or pericarditis with COVID-19 vaccination, immunization should still be recommended because the benefits likely outweigh the harms, study shows.
Pharmacy Times
AUGUST 9, 2023
Chad Worz, PharmD, BCGP, FASCP, discusses how vaccine hesitancy and misinformation about flu vaccines create barriers to annual flu immunizations.
Pharmacy Times
AUGUST 3, 2022
Increasing population immunity decreased transmission of COVID-19 and allowed for reductions in quarantine and testing, encouraging 2-dose vaccine and booster uptake.
Pharmacy Times
OCTOBER 28, 2022
Findings are encouraging for individuals with cancer who are receiving immune checkpoint inhibition treatment and want to get a third vaccine dose, investigators said.
Pharmacy Times
OCTOBER 17, 2022
A researcher suggests that novel immune modulating cancer therapies like cancer vaccines can be more effective and safer alternative to previous cancer immunotherapies.
Pharmacy Times
OCTOBER 13, 2022
Jeremy Graff, chief scientific officer at IMV, discusses why the development of viable cancer vaccines is a bit more slow-going in comparison to the fast-paced development of COVID-19 vaccines during the pandemic.
Pharmacy Times
MAY 24, 2023
Reporting vaccination data to Immunization Information Systems databases can support public health surveillance activities.
STAT
OCTOBER 25, 2023
Alison Buttenheim was floored by a sign she saw in her doctor’s office when she went to get the first jab of the two-dose shingles vaccine to protect her against painful flare-ups of varicella zoster. “Medicare patients cannot receive Tdap or zoster vaccines here. They need to obtain [them] at their pharmacy.
Drug Topics
JUNE 28, 2024
The updates follow the Advisory Committee for Immunization Practice meeting held June 26 to 28, 2024.
Drug Topics
AUGUST 2, 2024
The technology from Diakonos Oncology initiates a natural immune response that targets and eliminates cancer cells by activating cytotoxic TH1 cell signaling pathways.
STAT
MAY 13, 2024
The number of children who received their routine vaccinations declined during the pandemic, so public health officials have been focusing on getting kids back up to date. They should also be paying attention to adults as a new, first-of-its-kind report quantifying the economic impact of adult immunizations makes clear.
Pharmacy Times
JANUARY 22, 2024
The schedule includes RSV vaccination, along with updated versions of the COVID-19 vaccine.
Drug Topics
APRIL 30, 2024
Recent research on COVID-19 vaccination shows that vaccines help fight variants, led to lower cases among children in California, and that boosters provide longer lasting protection.
STAT
AUGUST 16, 2024
Pfizer and BioNTech said Friday that their combined mRNA vaccine candidate against influenza and Covid-19 showed a lower immune response against one type of influenza, influenza B, in a Phase 3 trial, a setback for the vaccine. ” Continue to STAT+ to read the full story…
STAT
OCTOBER 23, 2023
The risks of severe neonatal morbidity, neonatal death, and admission to the neonatal intensive care unit were all significantly lower during the first month of birth in infants whose mothers were vaccinated against Covid-19, and protection against the virus continued for up to six months after birth, according to a new study published Monday in JAMA (..)
STAT
MARCH 28, 2024
His former student Ali Ellebedy was gnawed by frustration as Covid shutdowns stalled his influenza research; it took until the summer, when mass vaccination planning hit his radar, before the same realization kicked in.
Pharmacy Times
FEBRUARY 13, 2024
The findings suggest that 6 months after vaccination with ARCT-154, individuals had a longer immune response.
Drug Topics
OCTOBER 3, 2024
Researchers suggest that vaccine champion programs could be a promising avenue to increasing immunization rates.
STAT
OCTOBER 6, 2023
If the Covid-19 pandemic has shown us one thing, it is how little we really know about how the human immune system works. Decoding and harnessing the power of the human immune system is one of the great frontiers of biomedicine. Read the rest…
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content